Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLDX | KYMR | APGE | ||
| Company | Celldex Therapeutics | Kymera Therapeutics Inc | Apogee Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 36.68 | 33.75 | 47.21 | ||
| High | 37.75 | 34.71 | 49.77 | ||
| Low | 36.68 | 33.67 | 47.21 | ||
| Last | 37.00 | 34.66 | 49.00 | ||
| Change | +0.70 | +1.29 | +1.87 | ||
| % Change | +1.93% | +3.87% | +3.97% | ||
| Volume | 499,000 | 428,500 | 207,000 | ||
| 20-Day Average Volume | 620,080 | 507,630 | 457,550 | ||
| Previous Close | 36.30 | 33.37 | 47.13 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 38.87 | 35.37 | 52.50 | ||
| 20-Day Raw Stochastic | 22.43% | 32.32% | 23.26% | ||
| 20-Day Relative Strength | 41.69% | 45.19% | 45.72% | ||
| Weighted Alpha | -5.03 | +17.53 | +47.43 | ||
| Today's Opinion | 8% Buy | 40% Buy | N/A | ||
| Previous Opinion | 8% Buy | 24% Buy | N/A | ||
| Last Month's Opinion | 80% Buy | 80% Buy | N/A | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.76% since 04/22/24 | +0.90% since 04/22/24 | +0.74% since 04/22/24 | ||
| Low | 35.65 on 04/26/24 | 32.75 on 04/25/24 | 43.60 on 04/25/24 | ||
| High | 39.67 on 04/23/24 | 37.01 on 04/23/24 | 51.00 on 04/23/24 | ||
| 1-Month | |||||
| %Chg | -11.84% since 03/28/24 | -13.78% since 03/28/24 | -26.26% since 03/28/24 | ||
| Low | 35.65 on 04/26/24 | 32.75 on 04/25/24 | 43.60 on 04/25/24 | ||
| High | 41.84 on 04/01/24 | 40.55 on 04/01/24 | 68.21 on 04/01/24 | ||
| 3-Month | |||||
| %Chg | +1.70% since 01/29/24 | +6.35% since 01/29/24 | +31.90% since 01/29/24 | ||
| Low | 34.65 on 02/02/24 | 30.99 on 02/02/24 | 32.78 on 02/02/24 | ||
| High | 53.18 on 03/04/24 | 45.31 on 02/27/24 | 72.29 on 03/13/24 | ||
| 6-Month | |||||
| %Chg | +63.64% since 10/27/23 | +215.95% since 10/27/23 | +210.91% since 10/27/23 | ||
| Low | 22.11 on 10/30/23 | 9.60 on 11/02/23 | 14.19 on 11/10/23 | ||
| High | 53.18 on 03/04/24 | 45.31 on 02/27/24 | 72.29 on 03/13/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,029,206 | 2,047,516 | 2,022,961 | ||
| Shares Outstanding, K | 55,901 | 61,358 | 42,923 | ||
| Annual Sales | 6,880,000 | 78,590,000 | 0 | ||
| Annual Net Income | -141,430,000 | -146,960,000 | -83,990,000 | ||
| Last Quarter Sales | 4,130,000 | 47,890,000 | 0 | ||
| Last Quarter Net Income | -43,310,000 | -14,370,000 | -31,740,000 | ||
| 60-Month Beta | 1.49 | 2.27 | N/A | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.57 on 02/26/24 | -0.25 on 02/22/24 | -0.32 on 03/05/24 | ||
| Latest Earnings Date | 05/02/24 | 05/02/24 | 06/04/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||